IB

Incyclix Bio

NC - Durham
Biotechnology

Focus: Precision treatments that target the aberrant proliferation driving many cancers

Incyclix Bio is a life sciences company focused on Precision treatments that target the aberrant proliferation driving many cancers.

Oncology
Funding Stage
SERIES B
Open Jobs
0

Pipeline & Clinical Trials

Phase 1/2
Clinical Trials (1)
NCT05735080Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Phase 1/2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 1 clinical trial